Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
NCT07302516
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
636
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
tezepelumab (Arm1&Arm2)
Sponsor
Qilu Pharmaceutical Co., Ltd.